Abstract
Oxytocin is known to have anti-anxiety and anti-stress effects. Using a fear-potentiated startle paradigm in rats, we previously demonstrated that subcutaneously administered oxytocin suppressed acoustic startle following fear conditioning compared with startle before fear conditioning (termed background anxiety), but did not have an effect on cue-specific fear-potentiated startle. The findings suggest oxytocin reduces background anxiety, an anxious state not directly related to cue-specific fear, but sustained beyond the immediate threat. The goal of the present study was to compare the effects of centrally and peripherally administered oxytocin on background anxiety and cue-specific fear. Male rats were given oxytocin either subcutaneously (SC) or intracerebroventricularly (ICV) into the lateral ventricles before fear-potentiated startle testing. Oxytocin doses of 0.01 and 0.1 μg/kg SC reduced background anxiety. ICV administration of oxytocin at doses from 0.002 to 20 μg oxytocin had no effect on background anxiety or cue-specific fear-potentiated startle. The 20 μg ICV dose of oxytocin did reduce acoustic startle in non-fear conditioned rats. These studies indicate that oxytocin is potent and effective in reducing background anxiety when delivered peripherally, but not when delivered into the cerebroventricular system. Oxytocin given systemically may have anti-anxiety properties that are particularly germane to the hypervigilance and exaggerated startle typically seen in many anxiety and mental health disorder patients.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Amico JA, Vollmer RR, Karam JR, Lee PR, Li X, Koenig JI et al (2004). Centrally administered oxytocin elicits exaggerated grooming in oxytocin null mice. Pharmacol, Biochem, Behav 78: 333–339.
Bale TL, Davis AM, Auger AP, Dorsa DM, McCarthy MM (2001). CNS region-specific oxytocin receptor expression: importance in regulation of anxiety and sex behavior. J Neurosci 21: 2546–2552.
Bartz J, Hollander E (2008). Oxytocin and experimental therapeutics in autism spectrum disorders. Prog Brain Res 170: 451–462.
Bartz JA, Zaki J, Bolger N, Hollander E, Ludwig NN, Kolevzon A et al (2010). Oxytocin selectively improves empathic accuracy. Psychol Sci 21: 1426–1428.
Bernier R, Dawson G, Panagiotides H, Webb S (2005). Individuals with autism spectrum disorder show normal responses to a fear potential startle paradigm. J Autism Dev Disord 35: 575–583.
Blume A, Bosch OJ, Miklos S, Torner L, Wales L, Waldherr M et al (2008). Oxytocin reduces anxiety via ERK1/2 activation: local effect within the rat hypothalamic paraventricular nucleus. Eur J Neurosci 27: 1947–1956.
Boccia MM, Kopf SR, Baratti CM (1998). Effects of a single administration of oxytocin or vasopressin and their interactions with two selective receptor antagonists on memory storage in mice. Neurobiol Learn Mem 69: 136–146.
Born J, Lange T, Kern W, McGregor GP, Bickel U, Fehm HL (2002). Sniffing neuropeptides: a transnasal approach to the human brain. Nat Neurosci 5: 514–516.
Brasnjevic I, Steinbusch HWM, Schmitz C, Martinez-Martinez P (2009). Delivery of peptide and protein drugs over the blood-brain barrier. Prog Neurobiol 87: 212–251.
Brunetti M, Sepede G, Mingoia G, Catani C, Ferretti A, Merla A et al (2010). Elevated response of human amygdala to neutral stimuli in mild post traumatic stress disorder: neural correlates of generalized emotional response. Neuroscience 168: 670–679.
Buijs R, de Vries G, van Leeuwen FW (1985). The distribution and synaptic release of oxytocin in the central nervous system, In: Amico J, Robinson A (eds). Oxytocin: Clincial and Laboratory Studies. Elsevier: Amsterdam. pp 77–86.
Buijs RM (1980). Immunocytochemical demonstration of vasopressin and oxytocin in the rat brain by light and electron microscopy. J Histochem Cytochem 28: 357–360.
Carson DS, Hunt GE, Guastella AJ, Barber L, Cornish JL, Arnold JC et al (2010). Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus. Addict Biol 15: 448–463.
Carter C, Grippo A, Pournajafi-Nazarloo H, Ruscio M, Porges S (2008). Oxytocin, vasopressin and sociality. Prog Brain Res 170: 331–336.
Colbern DL, Gispen WH (1988). Neural mechanisms and biological significance of grooming behavior. Ann N Y Acad Sci 525: ix–x.
Davis M, Falls WA, Campeau S, Kim M (1993). Fear-potentiated startle: a neural and pharmacological analysis. Behav Brain Res 58: 175–198.
Davis M, Walker DL, Miles L, Grillon C (2010). Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology 35: 105–135.
Davis M, Whalen PJ (2001). The amygdala: vigilance and emotion. Mol Psychiatry 6: 13–34.
de Oliveira LF, Camboim C, Diehl F, Consiglio AR, Quillfeldt JA (2007). Glucocorticoid-mediated effects of systemic oxytocin upon memory retrieval. Neurobiol Learn Mem 87: 67–71.
de Wied D, Gaffori O, Burbach JP, Kovács GL, van Ree JM (1987). Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviors of rats. J Pharmacol Exp Ther 241: 268–274.
Dichter GS, Benning SD, Holtzclaw TN, Bodfish JW (2010). Affective modulation of the startle eyeblink and postauricular reflexes in autism spectrum disorder. J Autism Dev Disord 40: 858–869.
Domes G, Heinrichs M, Gläscher J, Büchel C, Braus DF, Herpertz SC (2007). Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biol Psychiatry 62: 1187–1190.
Drago F, Pedersen CA, Caldwell JD, Prange AJ (1986). Oxytocin potently enhances novelty-induced grooming behavior in the rat. Brain Res 368: 287–295.
Durham DA, Banks WA, Kastin AJ (1991). Carrier-mediated transport of labeled oxytocin from brain to blood. Neuroendocrinology 53: 447–452.
Ermisch A, Barth T, Ruhle HJ, Skopkova J, Hrbas P, Landgraf R (1985). On the blood-brain barrier to peptides: accumulation of labeled vasopressin, DesGlyNH2-vasopressin and oxytocin by brain regions. Endocrinol Exp 19: 29–37.
Ermisch A, Brust P, Kretzschmar R, Rühle HJ (1993). Peptides and blood-brain barrier transport. Physiol Rev 73: 489–527.
Francis AB, Pace TW, Ginsberg AB, Rubin BA, Spencer RL (2006). Limited brain diffusion of the glucocorticoid receptor agonist RU28362 following i.c.v. administration: implications for i.c.v. drug delivery and glucocorticoid negative feedback in the hypothalamic-pituitary-adrenal axis. Neuroscience 141: 1503–1515.
Gibbs J, Kulkosky PJ, Smith GP (1981). Effects of peripheral and central bombesin on feeding behavior of rats. Peptides 2 (Suppl 2): 179–183.
Gimpl G, Fahrenholz F (2001). The oxytocin receptor system: structure, function, and regulation. Physiol Rev 81: 629–683.
Grillon C (2002). Startle reactivity and anxiety disorders: aversive conditioning, context, and neurobiology. Biol Psychiatry 52: 958–975.
Grillon C (2009). D-cycloserine facilitation of fear extinction and exposure-based therapy might rely on lower-level, automatic mechanisms. Biol Psychiatry 66: 636–641.
Grillon C, Baas J (2003). A review of the modulation of the startle reflex by affective states and its application in psychiatry. Clin Neurophysiol 114: 1557–1579.
Grillon C, Lissek S, Rabin S, Mcdowell D, Dvir S, Pine DS (2008). Increased anxiety during anticipation of unpredictable but not predictable aversive stimuli as a psychophysiologic marker of panic disorder. Am J Psychiatry 165: 898–904.
Grillon C, Morgan CA (1999). Fear-potentiated startle conditioning to explicit and contextual cues in Gulf War veterans with posttraumatic stress disorder. J Abnorm Psychol 108: 134–142.
Grillon C, Morgan III CA, Davis M, Southwick SM (1998). Effects of experimental context and explicit threat cues on acoustic startle in Vietnam veterans with posttraumatic stress disorder. Biol Psychiatry 44: 1027–1036.
Grillon C, Morgan CA, Southwick SM, Davis M, Charney DS (1996). Baseline startle amplitude and prepulse inhibition in Vietnam veterans with posttraumatic stress disorder. Psychiatry Res 64: 169–178.
Grillon C, Pine DS, Lissek S, Rabin S, Bonne O, Vythilingam M (2009). Increased anxiety during anticipation of unpredictable aversive stimuli in posttraumatic stress disorder but not in generalized anxiety disorder. Biol Psychiatry 66: 47–53.
Grippo AJ, Trahanas DM, Zimmerman II RR, Porges SW, Carter CS (2009). Oxytocin protects against negative behavioral and autonomic consequences of long-term social isolation. Psychoneuroendocrinology 34: 1542–1553.
Hogle JM, Kaye JT, Curtin JJ (2010). Nicotine withdrawal increases threat-induced anxiety but not fear: neuroadaptation in human addiction. Biol Psychiatry 68: 719–725.
Hollander E, Bartz J, Chaplin W, Phillips A, Sumner J, Soorya L et al (2007). Oxytocin increases retention of social cognition in autism. Biol Psychiatry 61: 498–503.
Hollander E, Novotny S, Hanratty M, Yaffe R, DeCaria CM, Aronowitz BR et al (2003). Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders. Neuropsychopharmacology 28: 193–198.
Johnson AK, Epstein AN (1975). The cerebral ventricles as the avenue for the dipsogenic action of intracranial angiotensin. Brain Res 86: 399–418.
Kirsch P, Esslinger C, Chen Q, Mier D, Lis S, Siddhanti S et al (2005). Oxytocin modulates neural circuitry for social cognition and fear in humans. J Neurosci 25: 11489–11493.
Kiss A, Mikkelsen JD (2005). Oxytocin—anatomy and functional assignments: a minireview. Endocr Regul 39: 97–105.
Klenerova V, Krejci I, Sida P, Hlinak Z, Hynie S (2009). Modulary effects of oxytocin and carbetocin on stress-induced changes in rat behavior in the open-field. J Physiol Pharmacol 60: 57–62.
Kosfeld M, Heinrichs M, Zak PJ, Fischbacher U, Fehr E (2005). Oxytocin increases trust in humans. Nature 435: 673–676.
Liberzon I, Sripada CS (2008). The functional neuroanatomy of PTSD: a critical review. Prog Brain Res 167: 151–169.
Mens WB, Witter A, van Wimersma Greidanus TB (1983). Penetration of neurohypophyseal hormones from plasma into cerebrospinal fluid (CSF): half-times of disappearance of these neuropeptides from CSF. Brain Res 262: 143–149.
Miles L, Davis M, Walker D (2011). Phasic and sustained fear are pharmacologically dissociable in rats. Neuropsychopharmacology 36: 1563–1574.
Missig G, Ayers LW, Schulkin J, Rosen JB (2010). Oxytocin reduces background anxiety in a fear-potentiated startle paradigm. Neuropsychopharmacology 35: 2607–2616.
Morgan CA, Grillon C, Southwick SM, Davis M, Charney DS (1995). Fear-potentiated startle in posttraumatic stress disorder. Biol Psychiatry 38: 378–385.
Neumann ID (2008). Brain oxytocin: a key regulator of emotional and social behaviors in both females and males. J Neuroendocrinol 20: 858–865.
Pardridge WM (2005). The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2: 3–14.
Petersson M, Alster P, Lundeberg T, Uvnas-Moberg K (1996). Oxytocin causes a long-term decrease of blood pressure in female and male rats. Physiol Behav 60: 1311–1315.
Petersson M, Hulting AL, Uvnas-Moberg K (1999). Oxytocin causes a sustained decrease in plasma levels of corticosterone in rats. Neurosci Lett 264: 41–44.
Pole N, Neylan TC, Best SR, Orr SP, Marmar CR (2003). Fear-potentiated startle and posttraumatic stress symptoms in urban police officers. J Traum Stress 16: 471–479.
Pole N, Neylan TC, Otte C, Henn-Hasse C, Metzler TJ, Marmar CR (2009). Prospective prediction of posttraumatic stress disorder symptoms using fear potentiated auditory startle responses. Biol Psychiatry 65: 235–240.
Reeb-Sutherland BC, Helfinstein SM, Degnan KA, Pérez-Edgar K, Henderson HA, Lissek S et al (2009). Startle response in behaviorally inhibited adolescents with a lifetime occurrence of anxiety disorders. J Am Acad Child Adolesc Psychiatry 48: 610–617.
Ring RH, Malberg JE, Potestio L, Ping J, Boikess S, Luo B et al (2006). Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications. Psychopharmacology (Berl) 185: 218–225.
Rosen JB, Schulkin J (1998). From normal fear to pathological anxiety. Psychol Rev 105: 325–350.
Rotzinger S, Lovejoy DA, Tan LA (2010). Behavioral effects of neuropeptides in rodent models of depression and anxiety. Peptides 31: 736–756.
Sawchenko P, Swanson L (1985). Relationship of oxytocin pathways to the control of neuroendocrine and autonomic function, In: Amico J, Robinson A (eds). Oxytocin: Clinical and Laboratory Studies. Elsevier: Amsterdam. pp 87–103.
Simeon D, Bartz J, Hamilton H, Crystal S, Braun A, Ketay S et al (2011). Oxytocin administration attenuates stress reactivity in borderline personality disorder: a pilot study. Psychoneuroendocrinology; doi:10.1016/j.psyneuen.2011.03.013.
Simpson JB (1975). Subfornical organ involvement in angiotensin-induced drinking, In: Fitzsimons JT, Peters-Haefeli L (eds). Control Mechanisms of Drinking. Springer-Verlag: New York.
Slattery DA, Neumann ID (2010). Chronic icv oxytocin attenuates the pathological high anxiety state of selectively bred Wistar rats. Neuropharmacology 58: 56–61.
Sofroniew MV (1983). Morphology of vasopressin and oxytocin neurones and their central and vascular projections. Prog Brain Res 60: 101–114.
Stivers JA, Kaltwasser MT, Hill PS, Hruby VJ, Crawley JN (1988). Ventral tegmental oxytocin induces grooming. Peptides 9 (Suppl 1): 223–231.
Tribollet E, Dubois-Dauphin M, Dreifuss JJ, Barberis C, Jard S (1992). Oxytocin receptors in the central nervous system. Distribution, development, and species differences. Ann N Y Acad Sci 652: 29–38.
Uvnäs-Moberg K, Ahlenius S, Hillegaart V, Alster P (1994). High doses of oxytocin cause sedation and low doses cause an anxiolytic-like effect in male rats. Pharmacol Biochem Behav 49: 101–106.
Van Erp AM, Kruk MR, De Kloet ER (1993a). Induction of grooming in resting rats by intracerebroventricular oxytocin but not by adrenocorticotropic hormone-(1–24) and alpha-melanocyte-stimulating hormone. Eur J Pharmacol 232: 217–221.
Van Erp AM, Kruk MR, Semple DM, Verbeet DW (1993b). Initiation of self-grooming in resting rats by local PVH infusion of oxytocin but not alpha-MSH. Brain Res 607: 108–112.
Veening JG, de Jong T, Barendregt HP (2010). Oxytocin-messages via the cerebrospinal fluid: behavioral effects; a review. Physiol Behav 101: 193–210.
Viviani D, Stoop R (2008). Opposite effects of oxytocin and vasopressin on the emotional expression of the fear response. Prog Brain Res 170: 207–218.
Walker DL, Davis M (2002a). Quantifying fear potentiated startle using absolute vs proportional increase scoring methods: implications for the neurocircuitry of fear and anxiety. Psychopharmacology (Berl) 164: 318–328.
Walker DL, Davis M (2002b). The role of amygdala glutamate receptors in fear learning, fear-potentiated startle, and extinction. Pharmacol Biochem Behav 71: 379–392.
Wilbarger JL, McIntosh DN, Winkielman P (2009). Startle modulation in autism: positive affective stimuli enhance startle response. Neuropsychologia 47: 1323–1331.
Windle RJ, Shanks N, Lightman SL, Ingram CD (1997). Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology 138: 2829–2834.
Acknowledgements
This work was supported by Grant W81XWH-08-1-0182 from the Congressionally Directed Medical Research Programs, U.S. Army Medical Research & Materiel Command.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Neuropsychopharmacology website
Supplementary information
Rights and permissions
About this article
Cite this article
Ayers, L., Missig, G., Schulkin, J. et al. Oxytocin Reduces Background Anxiety in a Fear-Potentiated Startle Paradigm: Peripheral vs Central Administration. Neuropsychopharmacol 36, 2488–2497 (2011). https://doi.org/10.1038/npp.2011.138
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/npp.2011.138
Keywords
This article is cited by
-
Pharmacological modulation of conditioned fear in the fear-potentiated startle test: a systematic review and meta-analysis of animal studies
Psychopharmacology (2023)
-
A midbrain-reticulotegmental circuit underlies exaggerated startle under fear emotions
Molecular Psychiatry (2022)
-
Activation of septal OXTr neurons induces anxiety- but not depressive-like behaviors
Molecular Psychiatry (2021)
-
Emotional remodeling with oxytocin durably rescues trauma-induced behavioral and neuro-morphological changes in rats: a promising treatment for PTSD
Translational Psychiatry (2020)
-
Oxytocin receptors in the dorsolateral bed nucleus of the stria terminalis (BNST) bias fear learning toward temporally predictable cued fear
Translational Psychiatry (2019)
